Effect of Antiplatelet Therapy on Thromboembolic Complications of Elective Coil Embolization of Cerebral Aneurysms

BACKGROUND AND PURPOSE: Thromboembolic events are the most common complications of elective coil embolization of cerebral aneurysms. Administration of oral clopidogrel and/or aspirin could lower the thromboembolic complication rate. MATERIALS AND METHODS: Records over a 10-year period were reviewed in a retrospective cohort study. For 369 consecutive elective coil embolization procedures, 25 patients received no antiplatelet drugs, 86 received antiplatelet drugs only after embolization, and 258 received antiplatelet drugs before and after embolization. RESULTS: Symptomatic thromboembolic complications (transient ischemic attack or stroke within 60 days) occurred in 4 (16%) of 25 when no antiplatelet drugs were given, in 2 (2.3%) of 86 when antiplatelet drugs were administered only after embolization, and in 5 (1.9%) of 258 when antiplatelet drugs were administered before and after embolization. The lower symptomatic thromboembolic complication rate in the patients who received any antiplatelet therapy was statistically significant (P = .004). Clots were visible intraprocedurally in 5 (4.5%) of 111 when no antiplatelet drugs were administered before procedures and in 4 (1.6%) of 258 when they were (P value not significant). None of the 9 was symptomatic postprocedurally, but 7 were lysed or mechanically disrupted. Extracerebral hemorrhagic complications occurred in 0 (0%) of 25 when no antiplatelet drugs were given and in 11 (3.2%) of 344 when they were (P value not significant). CONCLUSION: Oral clopidogrel and/or aspirin significantly lowered the symptomatic thromboembolic complication rate of elective coil embolization of unruptured cerebral aneurysms. There were trends toward a lower rate of intraprocedural clot formation in patients given antiplatelet drugs before procedures and a higher hemorrhagic complication rate in patients given antiplatelet drugs. Benefits of antiplatelet therapy appear to outweigh risks.

[1]  H. Zeumer,et al.  Intravenous Administration of Acetylsalicylic Acid During Endovascular Treatment of Cerebral Aneurysms Reduces the Rate of Thromboembolic Events , 2006, Stroke.

[2]  N Pouratian,et al.  Endovascular management of unruptured intracranial aneurysms , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  N. Kocer,et al.  Thromboembolic events associated with balloon-assisted coil embolization: evaluation with diffusion-weighted MR imaging. , 2004, AJNR. American journal of neuroradiology.

[4]  B. Dimitrov,et al.  Treatment of Unruptured Cerebral Aneurysms by Embolization with Guglielmi Detachable Coils: Case-fatality, Morbidity, and Effectiveness in Preventing Bleeding—A Systematic Review of the Literature , 2004, Neurosurgery.

[5]  Stephan Felber,et al.  Endovascular Coil Occlusion of 1811 Intracranial Aneurysms: Early Angiographic and Clinical Results , 2004, Neurosurgery.

[6]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[7]  R. Grubb,et al.  Postprocedure ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils. , 2002, Journal of neurosurgery.

[8]  A. Algra,et al.  Treatment of intracranial aneurysms by embolization with coils: a systematic review. , 1999, Stroke.

[9]  D. Pelz,et al.  Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. , 1998, AJNR. American journal of neuroradiology.

[10]  H. Henkes,et al.  Detection of microemboli distal to cerebral aneurysms before and after therapeutic embolization. , 1998, AJNR. American journal of neuroradiology.

[11]  Joon K. Song,et al.  Endovascular embolization of 150 basilar tip aneurysms with Guglielmi detachable coils: results of the Food and Drug Administration multicenter clinical trial. , 1998, Journal of neurosurgery.

[12]  F Viñuela,et al.  Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients. , 1997, Journal of neurosurgery.

[13]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[14]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[15]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .